Microbial transformation of 3,4-methylenedioxy-N-methylamphetamine and 3,4-methylenedioxyamphetamine

Canadian Journal of Microbiology

Volumn 42, Issue 8, 1996, Pages 851-854

  Foster, B C ^a   Wilson, D L ^a   Marwood, T ^a   Ethier, J C ^a   Zamecnik, J ^a  

^a Bureau of Drug Research   (Canada)

Author keywords

Cell proportions; Common bean; Delayed inoculation; Phaseolus vulgaris L.; Strain preference

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE;

BIOSYNTHESIS; BIOTRANSFORMATION; CONTROLLED STUDY; CUNNINGHAMELLA; FUNGUS GROWTH; METABOLITE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029760580     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/m96-107     Document Type: Short Survey

References (17)

1. Adams, M., Lennard, M.S., Otton, S.V., Tucker, G.T., and Woods, H.F. 1991. Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine type. Biochem. Pharmacol. 42: 947-949.
2. Caldwell, J. 1976. The metabolism of amphetamines in mammals. Drug Metab. Rev. 5: 219-280.
3. Clarke, A.M., McChesney, J.D., and Hufford, C.D. 1985. The use of microorganisms for the study of drug metabolism. Med. Res. Rev. 5: 231-253.
4. Coutts, R.T., Foster, B.C., Jones, G.R., and Myers, G.E. 1979. Metabolism of (±)-N-(n-propyl)amphetamine by Cunninghamella echinulata. Appl. Environ. Microbiol. 37: 429-432.
5. Foster, B.C., Coutts, R.T., Pasutto, F.M., and Mozayani, A. 1988. Microbial metabolism of phenelzine and pheniprazine. Life Sci. 42: 285-292.
6. Foster, B.C., Coutts, R.T., and Pasutto, F.M., 1989a. Biotransformation of aryl alkylamines by Cunninghamella bainieri. Xenobiotica, 19: 531-538.
7. Foster, B.C., Wilson, D.L., and McGilveray, I.J. 1989b. Effect of sparteine and quinidine on the metabolism of methoxyphenamine by Cunninghamella bainieri. Xenobiotica, 19: 445-452.
8. Foster, B.C., Litster, D.L., and Lodge, B.A. 1991. Biotransformation of 2-, 3-, and 4-methoxyamphetamines by Cunninghamella echinulata. Xenobiotica, 21: 1337-1346.
9. Geertsen, S., Foster, B.C., Wilson, D.L., Cyr, T.D., and Casley, W. 1995. Metabolism of methoxyphenamine and 2-methoxyamphetamine in CYP2D6 transfected cells and cell preparations. Xenobiotica, 25: 895-906.
10. Gollamudi, R., Ali, S.F., Lipe, G., Newport, G., Webb, P., Lopez, M., Leakey, J.E.A.. Kolta, M., and Slikker, W. 1989. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Neurotoxicology, 10: 455-466.
11. Hiramatsu, M., Kumagai, Y., Unger, S., and Cho, A.K. 1990. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther. 254: 521-527.
12. Kerry, N.L., Somogyi A.A., Bochner, F., and Mikus, G. 1994. The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes. Br. J. Clin. Pharmacol. 38: 243-248.
13. Lim, H.K., and Foltz, R.L. 1988. In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector. Chem. Res. Toxicol. 1: 370-378.
14. Lim, H.K., and Foltz, R.L. 1991. In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques. Biol. Mass Spectrom. 20: 677-686.
15. Midha, K.K. 1974. Identification of two in vitro metabolites of 3,4-methylenedioxyamphetamine by gas-liquid chromatography-mass spectrometry. J. Chromatogr. 101: 210-214.
16. Smith, R. V., and Rosazza, J.P. 1975. Microbial models of mammalian metabolism. J. Pharm. Sci. 64: 1737-1759.
17. Yousif, M.Y., Fitzgerald, R.L., Narasimhachari, N., Rosecrans, J.A., Blanke, R.V., and Glennon, R.A. 1990. Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats. Drug Alcohol Depend. 26: 127-135.